These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 44904)

  • 1. [Platelet factor 3 (PF3) and primary hemostasis: ditazol test].
    Di Micco B; Boeri F; Pagliara E; Cinque MR; Messina MF; Marcacci M
    Pediatria (Napoli); 1979 Jun; 87(2):237-43. PubMed ID: 44904
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition of primary hemostasis and the coagulative pathway].
    Di Micco B; Cinque MR; Pagliara E; Ciccone S; Messina MF; De Felice MG; Del Guercio R; Marcacci M
    Pediatria (Napoli); 1979 Jun; 87(2):219-26. PubMed ID: 44903
    [No Abstract]   [Full Text] [Related]  

  • 3. [Potassium, magnesium, copper, manganese and cobalt salts of aspartic acid on platelet factor 3 availability (author's transl)].
    Reuter HD; Schröter G
    Arzneimittelforschung; 1980; 30(12):2106-8. PubMed ID: 7194069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet antibody determination by platelet factor 3 assay (comparison with radiolabelled serotonin release and platelet aggregometry).
    Leone G; Breda M; Accorrà F; Bizzi B
    Ric Clin Lab; 1978; 8(3):141-7. PubMed ID: 746295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombocyte functions in diabetics with proliferative retinopathy and in normal persons].
    Peters KM; Reuter HD
    Med Klin (Munich); 1986 Jun; 81(14):477-80. PubMed ID: 3785033
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in the thrombocyte and plasma factors of hemostasis in amyloidosis].
    Charyev BM; Kozlovskaia LV; Mishchenko AL; Kozlovskaia NL; Karryeva BCh
    Ter Arkh; 1990; 62(6):75-9. PubMed ID: 2218933
    [No Abstract]   [Full Text] [Related]  

  • 7. [Platelet aggregation and various coagulation parameters in liver cirrhosis].
    Calabrese S; Giansante C; Sammartini C; Benedetti A
    Minerva Med; 1984 Apr; 75(18):1047-52. PubMed ID: 6728255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of human plasma lipoproteins on platelet aggregation and platelet factor 3 activity in vitro.
    Miller NE; Nordoy A
    Atherosclerosis; 1977 Oct; 28(2):181-6. PubMed ID: 199206
    [No Abstract]   [Full Text] [Related]  

  • 9. [Platelet factor 3 and 4 in juvenile diabetes and in children of diabetic mothers].
    Calabrese S; Giansante C; Burigana F; Feruglio FS
    Minerva Med; 1981 Sep; 72(34):2255-60. PubMed ID: 7290451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased platelet aggregation, Ca2+ and Mg2+ ATPase and platelet factor 3 activities in patients with Wilson disease.
    Cohen AM; Brettbart H; Creter D; Levinsky H; Frydman M; Djaldetti M
    Haematologica; 1984; 69(3):263-71. PubMed ID: 6147299
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of platelet factor 3 by thrombin generation using a micro-coagulation assay.
    Kirchhof B; Balleisen L
    Thromb Res; 1982 Aug; 27(3):303-10. PubMed ID: 6890246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for appearance of "lysis independent" procoagulant activities in collagen or thrombin stimulated platelets.
    Brox JH; Osterud B
    Thromb Res; 1983 Jun; 30(5):449-58. PubMed ID: 6612678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Platelet factor 3].
    Isobe J
    Rinsho Byori; 1987 Jun; Spec No 71():183-91. PubMed ID: 3306039
    [No Abstract]   [Full Text] [Related]  

  • 14. [The determination of platelet factor 3 using hirudin].
    Wamhoff D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(1):82-7. PubMed ID: 50972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human platelet aggregation tests in vitro. Effects of dilazep.
    Ponari O; Manotti C
    Arzneimittelforschung; 1981; 31(1):97-101. PubMed ID: 7194099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phospholipids and platelet procoagulant activity in myeloproliferative syndromes].
    Martínez E; César J; Navarro JL; Mercado A; Pardo A; García Avello A; García Frade J
    Sangre (Barc); 1985; 30(1):22-7. PubMed ID: 4039850
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiopulmonary bypass. Associated hemostatic abnormalities.
    Kalter RD; Saul CM; Wetstein L; Soriano C; Reiss RF
    J Thorac Cardiovasc Surg; 1979 Mar; 77(3):427-35. PubMed ID: 762986
    [No Abstract]   [Full Text] [Related]  

  • 18. [Platelet factor 3 (P-F-3) in chronic renal failure. Effect of dialysis].
    Lasierra Cirujeda J; Sánchez Casajus A; Vilades Juan E
    Rev Clin Esp; 1980 Mar; 156(5):321-4. PubMed ID: 7384579
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behavior of platelet aggregation in the postoperative period after ditazol treatment].
    Famulari C; Perri S; Terranova ML; Versaci A; Cuzzocrea D; Barberi I
    Clin Ter; 1982 Dec; 103(6):601-21. PubMed ID: 6130867
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of risk factors and blood coagulation parameters in cerebral ischemia].
    Xerra A; Arena A; Colosi P; Serra S
    Riv Neurol; 1986; 56(4):218-24. PubMed ID: 3563310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.